Evaluation of Stability and TLC Fingerprinting of the Artemether Component in Artemether-Lumefantrine Combination Suspension Formulations Available in Nigeria Pharmaceutical Market
Benjamin U. Ebeshi, Samuel J. Bunu, Chika L. Egemba, Edebi N. Vaikosen & Adesegun Kashimawo · Asian Journal of Research in Medical and Pharmaceutical Sciences · 2023
Aim: Artemether is the main component of the artemisinin-based combination therapy (ACT), used in the management of malaria infection caused by Plasmodium falciparum. Hence, its stability and conformation to pharmacopeia standards are necessary for use. The study aimed to review...
Open access
Research Article
10.9734/ajrimps/2023/v12i4241